{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:06:47Z","timestamp":1788260807023,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The present study aims to evaluate the survival status of patients with gallbladder cancer (GBC) and explore the prognostic factors for the improvement and preventions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study consists of 176 patients with clinically diagnosed gallbladder cancer; the study was conducted between 2019 and 2021 registered at Kamala Nehru Memorial Cancer Hospital, Prayagraj, India. The survival rates were analyzed by the Kaplan-Meier method; survival rate difference was analyzed by log-rank test, prognosis factors; and hazard ratio for mortality outcomes was estimated using Cox regression method.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The overall median survival time of patients was 5 months with the 1-year, 2-year, and 3-year survival rates of 24.4%, 8.5%, and 4.5%, respectively. The 3-year survival for patients with jaundice was 2.9%, liver infiltration (4.2%), gallstones (0.8%), and with advanced tumor grade (1.4%). Elderly GBC patients had lower survival rates (3.8%), while the 3-year overall survival for patients residing in urban areas dropped to zero. No patients in the tumor stage (T3\/T4) and with distance metastasis stage survived in 3 years, while only 1.1% of patients with advanced nodal stage survived. On receiving surgery and radiation therapy, the 3-year survival rate increased to 19.5% and 35%, respectively. The results of multivariate analysis showed that urban region (<jats:italic>HR<\/jats:italic> = 1.568, <jats:italic>p<\/jats:italic> = 0.040), gallstone or not (1.571, <jats:italic>p<\/jats:italic> = 0.049), N stage (<jats:italic>HR<\/jats:italic> = 1.468, <jats:italic>p<\/jats:italic> = 0.029), and M stage (<jats:italic>HR<\/jats:italic> = 2.289, <jats:italic>p<\/jats:italic> &lt; 0.0001) were independent risk factors for prognosis, while surgery or not (<jats:italic>HR<\/jats:italic> = 0.573, <jats:italic>p<\/jats:italic> = 0.030) was the protective factor for the prognosis of GBC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The overall survival of GBC in the Gangetic belt is poor. The geographical region of patients, gallstones, and N and M stage was the risk factors for prognosis, while surgery or not was the protective factor for the prognosis of GBC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12957-022-02857-y","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T06:02:51Z","timestamp":1671516171000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Survival analysis and prognostic factors of the carcinoma of gallbladder"],"prefix":"10.1186","volume":"20","author":[{"given":"Zainab","family":"Feroz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish C.","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,20]]},"reference":[{"key":"2857_CR1","first-page":"304","volume":"2","author":"SS Mhatre","year":"2016","unstructured":"Mhatre SS, Nagrani RT, Budukh A, Chiplunkar S, Badwe R, Patil P, et al. Place of birth and risk of gallbladder cancer in India. Indian J Cancer. 2016;2:304\u20138.","journal-title":"Indian J Cancer."},{"key":"2857_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.21037\/cco.2019.08.13","volume":"8","author":"MA Schmidt","year":"2019","unstructured":"Schmidt MA, Marcano-Bonilla L, Roberts LR. Gallbladder cancer: epidemiology and genetic risk associations. Chin Clin Oncol. 2019;8:31.","journal-title":"Chin Clin Oncol."},{"key":"2857_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.21037\/cco.2019.08.03","volume":"8","author":"U Dutta","year":"2019","unstructured":"Dutta U, Bush N, Kalsi D, Popli P, Kapoor VK. Epidemiology of gallbladder cancer in India. Chin Clin Oncol. 2019;8:33.","journal-title":"Chin Clin Oncol."},{"key":"2857_CR4","first-page":"145","volume-title":"Why is gallbladder cancer common in the gangetic belt? In book: Perspectives in Cancer Prevention-Translational Cancer Research","author":"R Dixit","year":"2014","unstructured":"Dixit R, Shukla VK. Why is gallbladder cancer common in the gangetic belt? In book: Perspectives in Cancer Prevention-Translational Cancer Research; 2014. p. 145\u201351."},{"key":"2857_CR5","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/jpm12020234","volume":"12","author":"P P\u00e9rez-Moreno","year":"2022","unstructured":"P\u00e9rez-Moreno P, Riquelme I, Garc\u00eda P, Brebi P, Roa JC. Environmental and lifestyle risk factors in the carcinogenesis of gallbladder cancer. J Pers Med. 2022;12:234.","journal-title":"J Pers Med."},{"key":"2857_CR6","doi-asserted-by":"publisher","first-page":"657","DOI":"10.18410\/jebmh\/2021\/129","volume":"8","author":"A Sreen","year":"2021","unstructured":"Sreen A, Singh HP, Guleria V, Verma N. Relation of gallbladder cancer, gallbladder stones and breast cancer with polluted rivers \u2013 a case control study in the Indo-Gangetic plains. J Evid Based Med Health. 2021;8:657\u201361.","journal-title":"J Evid Based Med Health."},{"key":"2857_CR7","first-page":"43","volume":"6","author":"M Roy","year":"2020","unstructured":"Roy M, Shamim F. Research on the impact of industrial pollution on river Ganga: a review. IJPCIP. 2020;6:43\u201351.","journal-title":"IJPCIP."},{"key":"2857_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.envint.2018.05.015","volume":"117","author":"S Dwivedi","year":"2018","unstructured":"Dwivedi S, Mishra S, Tripathi RD. Ganga water pollution: a potential health threat to inhabitants of Ganga basin. Environ Int. 2018;117:327\u201338.","journal-title":"Environ Int."},{"key":"2857_CR9","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1093\/carcin\/bgm138","volume":"28","author":"AS Soliman","year":"2007","unstructured":"Soliman AS, Lo AC, Banerjee M, El-Ghawalby N, Khaled HM, Bayoumi S, et al. Differences in K-ras and p53 gene mutations among pancreatic adenocarcinomas associated with regional environmental pollution. Carcinogenesis. 2007;28:1794\u20139.","journal-title":"Carcinogenesis."},{"key":"2857_CR10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41392-020-00324-2","volume":"5","author":"X Song","year":"2020","unstructured":"Song X, Hu Y, Li Y, Shao R, Liu F, Liu Y. Overview of current targeted therapy in gallbladder cancer. Signal Transduc Target Ther. 2020;5:230.","journal-title":"Signal Transduc Target Ther."},{"key":"2857_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin."},{"key":"2857_CR12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s12262-009-0095-3","volume":"71","author":"D Pandey","year":"2009","unstructured":"Pandey D. Surgical management of gallbladder cancer. Indian J Surg. 2009;71:363\u20137.","journal-title":"Indian J Surg."},{"key":"2857_CR13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1440-1746.2005.03576.x","volume":"20","author":"Y Batra","year":"2005","unstructured":"Batra Y, Pal S, Dutta U, Desi P, Garg PK, Makharia G, et al. Gallbladder cancer in India: a dismal picture. J Gastroenterol Hepatol. 2005;20:309\u201314.","journal-title":"J Gastroenterol Hepatol."},{"issue":"2","key":"2857_CR14","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1634\/theoncologist.2009-0302","volume":"15","author":"AX Zhu","year":"2010","unstructured":"Zhu AX, Hong TS, Hezel AF, Kooby DA. Current management of gallbladder carcinoma. Oncologist. 2010;15(2):168\u201381.","journal-title":"Oncologist."},{"key":"2857_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.21037\/cco.2019.07.03","volume":"8","author":"MR Acharya","year":"2019","unstructured":"Acharya MR, Patkar S, Parray A, Goel M. Management of gallbladder cancer in India. Chin Clin Oncol. 2019;8:35.","journal-title":"Chin Clin Oncol."},{"key":"2857_CR16","first-page":"e2020053","volume":"4","author":"K Shridhar","year":"2020","unstructured":"Shridhar K, Kapoor R, Goodman M, Kondal D, Narang K, Singh P, et al. Lung and gallbladder cancer survival in North India: an ambidirectional feasibility cohort study using telephone interviews. J Glob Health Rep. 2020;4:e2020053.","journal-title":"J Glob Health Rep."},{"key":"2857_CR17","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1007\/s12029-019-00347-1","volume":"51","author":"BP Singh","year":"2020","unstructured":"Singh BP, Khan WF, Rathore YS, Pol MM. Incidental carcinoma gallbladder: incidence, risk factors, and factors affecting survival\u20145-year experience from a tertiary care institute. J Gastrointest Cancer. 2020;51:980\u20137.","journal-title":"J Gastrointest Cancer."},{"key":"2857_CR18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41598-017-00491-3","volume":"7","author":"ZQ Cai","year":"2017","unstructured":"Cai ZQ, Guo P, Si SB, Geng ZM, Chen C, Cong LL. Analysis of prognostic factors for survival after surgery for gallbladder cancer based on a Bayesian network. Sci Rep. 2017;7:293.","journal-title":"Sci Rep."},{"key":"2857_CR19","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1002\/ijc.25421","volume":"127","author":"E Bertran","year":"2010","unstructured":"Bertran E, Heise K, Andia ME, Ferreccio C. Gallbladder cancer: incidence and survival in a high-risk area of Chile. Int. J. Cancer. 2010;127:2446\u201354.","journal-title":"Int. J. Cancer."},{"key":"2857_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12995-016-0128-3","volume":"11","author":"Z Singh","year":"2016","unstructured":"Singh Z, Chadha P. Textile industry and occupational cancer. J Occup Med Toxicol. 2016;11:39.","journal-title":"J Occup Med Toxicol."},{"key":"2857_CR21","doi-asserted-by":"publisher","first-page":"6832","DOI":"10.3390\/su13126832","volume":"13","author":"MF Hasan","year":"2021","unstructured":"Hasan MF, Nur-E-Alam F, Salam MA, Rahman H, Paul SC, Rak AE, et al. Health risk and water quality assessment of surface water in an urban river of Bangladesh. Sustainability. 2021;13:6832.","journal-title":"Sustainability."},{"key":"2857_CR22","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1038\/ajg.2016.345","volume":"111","author":"S Ryu","year":"2016","unstructured":"Ryu S, Chang Y, Yun KE, Jung SH, Shin JH, Shin H. Gallstones and the risk of gallbladder cancer mortality: a cohort study. Am J Gastroenterol. 2016;111:1476\u201387.","journal-title":"Am J Gastroenterol."},{"key":"2857_CR23","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/jso.20529","volume":"93","author":"M Tewari","year":"2006","unstructured":"Tewari M. Contribution of silent gallstones in gallbladder cancer. J Surg Oncol. 2006;93:629\u201332.","journal-title":"J Surg Oncol."},{"key":"2857_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/jso.20831","volume":"96","author":"P Mojica","year":"2007","unstructured":"Mojica P, Smith D, Ellenhorn J. Adjuvant radiation therapy is associated with improved survival for gallbladder carcinoma with regional metastatic disease. J Surg Oncol. 2007;96:8\u201313.","journal-title":"J Surg Oncol."},{"key":"2857_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.21037\/cco.2019.07.05","volume":"8","author":"AA Azizi","year":"2019","unstructured":"Azizi AA, Lamarca A, Valle JW. Systemic therapy of gallbladder cancer: review of first line, maintenance, neoadjuvant and second line therapy specific to gallbladder cancer. Chin Clin Oncol. 2019;8:43.","journal-title":"Chin Clin Oncol."},{"key":"2857_CR26","doi-asserted-by":"publisher","first-page":"967472","DOI":"10.1155\/2015\/967472","volume":"2015","author":"R Kanthan","year":"2015","unstructured":"Kanthan R, Senger JL, Ahmed S, Kanthan SC. Gallbladder cancer in the 21st century. J Oncol. 2015;2015:967472.","journal-title":"J Oncol."},{"key":"2857_CR27","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s13193-014-0317-4","volume":"5","author":"B Sirohi","year":"2014","unstructured":"Sirohi B, Singh A, Jagannath P, Shrikhande SV. Chemotherapy and targeted therapy for gallbladder cancer. Indian J Surg Oncol. 2014;5:134\u201341.","journal-title":"Indian J Surg Oncol."},{"key":"2857_CR28","doi-asserted-by":"publisher","first-page":"106234","DOI":"10.1016\/j.ijsu.2022.106234","volume":"98","author":"CF Feo","year":"2022","unstructured":"Feo CF, Ginesu GC, Fancellu A, Perra T, Ninniri C, Deiana G, et al. Current management of incidental gallbladder cancer a review. Int J Surg. 2022;98:106234.","journal-title":"Int J Surg."},{"key":"2857_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jnci.2015.07.004","volume":"28","author":"S Mallick","year":"2016","unstructured":"Mallick S, Benson R, Haresh KP, Julka PK, Rath GK. Adjuvant radiotherapy in the treatment of gall bladder carcinoma: what is the current evidence. J Egypt Natl Canc Inst. 2016;28:1\u20136.","journal-title":"J Egypt Natl Canc Inst."},{"issue":"12","key":"2857_CR30","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3390\/cancers12040918","volume":"9","author":"LE de Savornin","year":"2020","unstructured":"de Savornin LE, de Bitter T, Verhoeven R, van der Geest L, Hagendoorn J, Haj Mohammad N, et al. Trends in treatment and survival of gallbladder cancer in the Netherlands; identifying gaps and opportunities from a nation-wide cohort. Cancers (Basel). 2020;9(12):918.","journal-title":"Cancers (Basel)."}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-022-02857-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-022-02857-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-022-02857-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T03:15:11Z","timestamp":1671851711000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-022-02857-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,20]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2857"],"URL":"https:\/\/doi.org\/10.1186\/s12957-022-02857-y","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,20]]},"assertion":[{"value":"11 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Population Resource and Research Centre, Prayagraj Institute Ethical Committee (IERB Reference 9.43), and the consent from the patients was obtained prior to the execution of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"403"}}